Status:
ENROLLING_BY_INVITATION
Observation of Clozapine Treatment Safety in Bipolar Disorder.
Lead Sponsor:
Medical University of Gdansk
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of the registry is to record incidence of adverse events during treatment with clozapine in patients suffering from bipolar disorder.
Detailed Description
Bipolar disorder, with its spectrum, remains a life-long and significant mental health concern due to its unpredictable nature and varied symptomatology. Despite the wide array of available treatments...
Eligibility Criteria
Inclusion
- Diagnosis of treatment-resistant depressive episode in the course of bipolar disorder according to DSM-5.
- Age from 18 to 65 years old.
Exclusion
- Patients unable to give fully written informed consent
- Patients unable to comply with the requirements
Key Trial Info
Start Date :
February 23 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06011460
Start Date
February 23 2023
End Date
June 30 2027
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, Medical University of Gdańsk
Gdansk, Pomeranian Voivodeship, Poland, 80-214